Only 33% of Physicians Believe Prior Authorization Pledges Will Work, AMA Survey Finds

The relationship between healthcare providers and insurance payers has long been fraught with tension, but a recent survey from the American Medical Association (AMA) suggests a deepening rift over the issue of prior authorization. While major insurers have issued voluntary pledges to streamline the process and reduce administrative friction, the physicians on the front lines remain profoundly skeptical.

According to the survey, only 33% of physicians believe that these voluntary pledges made by major insurers will result in any meaningful difference to the industry. This lack of confidence underscores a systemic frustration with a process that many doctors argue prioritizes cost-containment over clinical judgment and patient safety.

Prior authorization—the requirement that a healthcare provider obtain approval from a health insurance plan before a specific service, medication, or device is provided—has become one of the most contentious points of friction in modern medicine. For the global medical community, this is not merely a matter of paperwork; This proves a struggle over who decides the course of patient care: the physician with the patient in the room, or an insurance adjuster behind a screen.

As the healthcare industry moves toward more integrated, value-based care models, the persistence of these administrative hurdles raises critical questions about the efficiency of current healthcare policy and the sustainability of the medical workforce.

The Gap Between Pledges and Practice

The skepticism voiced by physicians in the AMA survey stems from a history of “voluntary” reforms that often fail to materialize in the clinic. In recent years, several major payers have promised to reduce the burden of prior authorization by implementing “gold carding” programs—where physicians with a high historical rate of approval are exempted from the requirement—and by expanding the lists of services that do not require pre-approval.

However, for the majority of practitioners, these changes have felt marginal. The administrative burden on physicians remains a primary driver of burnout. The process often involves repetitive phone calls, the submission of redundant clinical documentation, and lengthy wait times that can delay critical treatments. When only one-third of doctors believe these pledges will work, it suggests that the trust between the clinical community and the insurance industry has reached a nadir.

The core of the conflict lies in the nature of “voluntary” pledges. Without regulatory mandates or standardized enforcement, physicians argue that insurers can selectively apply reforms or introduce new hurdles that offset the benefits of the promised improvements. This creates a “cat-and-mouse” game where clinicians spend more time navigating insurance portals than treating patients.

Understanding the Impact of Prior Authorization

To understand why this issue is so volatile, it is necessary to examine how prior authorization functions as a tool for utilization management. From the insurer’s perspective, these checks are designed to ensure that the most cost-effective and clinically appropriate treatments are used, preventing unnecessary or potentially harmful procedures.

In practice, however, the impact on patient access to care can be severe. When a life-saving medication or a necessary diagnostic scan is delayed by days or weeks due to a pending authorization, the clinical outcome for the patient can worsen. This “denial of care” or “delay of care” is often cited by physicians as the most distressing aspect of the process, transforming a bureaucratic hurdle into a clinical risk.

The burden is not shared equally across specialties. Specialists in oncology, rheumatology, and rare diseases often face the most stringent prior authorization requirements, as the medications they prescribe are frequently high-cost biologics. This creates a paradox where the sickest patients—those requiring the most complex and expensive therapies—face the highest administrative barriers to receiving them.

Regulatory Shifts: The Role of CMS

Recognizing that voluntary pledges are insufficient, government regulators have begun to step in. In the United States, the Centers for Medicare & Medicaid Services (CMS) has taken significant steps to standardize and streamline the process. A pivotal development was the issuance of the CMS-0057-F final rule, which aims to reduce the burden of prior authorization for Medicare Advantage plans.

The CMS rule introduces several mandates designed to bring transparency and efficiency to the process, including:

• Electronic Prior Authorization: Requiring plans to implement electronic processes for requesting and receiving authorizations, moving away from the antiquated reliance on fax machines.
• Faster Turnaround Times: Establishing strict deadlines for decisions—often requiring responses within 72 hours for urgent requests and 7 calendar days for standard requests.
• Transparency: Requiring insurers to publish their prior authorization criteria and the specific clinical reasons for any denials.
• Standardized Documentation: Limiting the amount of redundant information a physician must provide to justify a treatment.

While these mandates provide a more robust framework than voluntary pledges, the medical community remains cautious. The effectiveness of the CMS rule depends heavily on how strictly it is enforced and whether private insurers adopt similar standards for non-Medicare patients.

The Human Cost: Burnout and Patient Safety

The systemic friction caused by prior authorization contributes directly to the global crisis of physician burnout. When doctors spend hours of their unpaid time on “pajama time”—the hours after a clinical day spent finishing electronic health record (EHR) entries and fighting insurance denials—it erodes their professional satisfaction and mental health.

This is not just an issue of convenience; it is a public health concern. A burnt-out physician is more prone to errors and more likely to leave the profession, exacerbating existing healthcare shortages. The AMA has frequently highlighted that the administrative burden is a leading cause of physicians abandoning clinical practice altogether.

Beyond the provider, the patient experience is often one of confusion and anxiety. Patients are frequently told by their doctors that a treatment is medically necessary, only to be told by their insurance company that it is not. This contradiction undermines the patient-provider relationship and can lead patients to believe their doctor is incompetent or that their insurance company is acting in bad faith.

What Real Reform Looks Like

For physicians to move from skepticism to confidence, reform must move beyond surface-level pledges. True reform requires a fundamental shift in how medical necessity is determined and how that determination is communicated.

Key pillars of a functional system would include:

• Clinical Autonomy: Greater deference to the prescribing physician’s expertise, particularly for evidence-based treatments that are standard of care.
• Real-Time Integration: Prior authorization checks integrated directly into the EHR workflow, allowing doctors to know instantly if a drug is covered before the patient leaves the office.
• Independent Review: A streamlined, independent appeals process where the reviewer has the same level of specialty expertise as the prescribing physician.
• Gold Carding as a Standard: Moving “gold carding” from a voluntary perk to a standardized industry practice for providers who consistently meet clinical guidelines.

The shift toward value-based care—where providers are paid based on patient outcomes rather than the volume of services—offers a potential path forward. In a truly value-based system, the incentive for insurers shifts from denying individual services to ensuring the patient achieves the best overall health outcome, which naturally reduces the need for restrictive prior authorization.

Looking Ahead: The Path to Resolution

The 33% confidence level reported by the AMA is a stark reminder that the medical community does not view the current trajectory of insurer-led reform as sufficient. While the CMS final rule provides a necessary regulatory floor, the gap between policy and the daily reality of clinical practice remains wide.

The coming months will be critical as the industry monitors the implementation of electronic prior authorization mandates and the actual impact of the CMS rules on patient wait times. The focus will likely shift toward whether these standards are adopted across the entire private insurance market or if they remain limited to government-funded plans.

As the healthcare landscape continues to evolve, the tension between cost-containment and clinical necessity will remain a central conflict. However, for the sake of both provider well-being and patient safety, the industry must move toward a system where the “pledge” is replaced by a verifiable, transparent, and efficient standard of care.

Next Checkpoint: Industry analysts and medical associations will be monitoring the 2026 compliance reports from Medicare Advantage plans to determine if the CMS-mandated turnaround times and electronic submission requirements are being met in practice.

Do you believe prior authorization reform is possible without government intervention? Share your thoughts in the comments below or share this article with your colleagues to join the conversation.